Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ondansetron is effective in treating diarrhea-predominant irritable bowel syndrome

Nov. 4, 2011

Boceprevir improves hepatitis C treatment in patients coinfected with HIV

Nov. 4, 2011

Phosphodiesterase 5 inhibitor improves portal hypertension in open-label trial

Nov. 4, 2011

Long-term daclizumab therapy analyzed in patients with MS

Nov. 4, 2011

New therapeutic approach suggested for achalasia / News in Context

Nov. 3, 2011

Candidate vaccine for CDI-associated diarrhea is immunogenic and well tolerated

Nov. 3, 2011

Potential new target for MS therapy discovered at U.S. univeristy

Nov. 3, 2011

Initial treatment phase of rabeprazole trial in pediatric patients completed

Nov. 3, 2011

Additional data disclosed from ALLEGRO and BRAVO trials of laquinimod in RRMS

Nov. 3, 2011

Natural plant-derived product inhibits proliferation of gastric cancer cells

Nov. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...